FDA inspection
Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.: FDA inspection ending Feb 12, 2016
FDA inspection 958528 · Voluntary Action Indicated (VAI) · Tokushima
Key facts
| Inspection ID | 958528 |
|---|---|
| Firm | Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. |
| FEI number | 3002807834 |
| Address | 224-18, Kawauchi-Cho |
| City | Tokushima |
| Country | Japan |
| Fiscal year | 2016 |
| Inspection end date | Feb 12, 2016 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data